• Home
  • About Us
  • Technology
  • Pipeline
  • Partnerships
  • News & Publications
HDT Bio

GeekWire: COVID-19 Shots with Seattle Origins Reach Regulatory Milestones in South Korea, India

Jun 29, 2022 | In the News

Click here to view...

Spectrum News: The Quest is On for a “Universal” COVID-19 Vaccine, Is it Possible?

Mar 27, 2022 | In the News

Click here to view...

Clinical Trials Arena: HDT Bio dose first subjects in Phase I Covid-19 vaccine trial

Jan 19, 2022 | In the News

Click here to view...
Next Entries »

Recent Posts

  • Providence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
  • A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
  • KING5 Seattle Healthlink Feature: Seattle-based group testing new immunotherapy approach to treat deadly form of brain cancer
  • HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
  • FDA Greenlights HDT Bio’s First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease

Recent Comments

No comments to show.

Privacy Policy

Terms of Use

©2024 HDT Bio

  • Follow
  • Follow